TrialOrphanet journal of rare diseases2016

Safety and efficacy of vismodegib in patients with basal cell carcinoma nevus syndrome: pooled analysis of two trials.

Anne Lynn S Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.